Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nemaura Medical, Inc. (NASDAQ: NMRD).

Full DD Report for NMRD

You must become a subscriber to view this report.


Recent News from (NASDAQ: NMRD)

Nemaura Medical Strengthens Manufacturing Team in Preparation for SugarBEAT® Commercial Launch.
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today announced it has expanded its ma...
Source: GlobeNewswire
Date: August, 28 2018 04:00
Nemaura Medical Inc. Reports First Quarter 2018 Financial Results
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today reported financial results for the first quarter ended June 30, 2018. Rece...
Source: GlobeNewswire
Date: August, 09 2018 04:00
Your Daily Pharma Scoop: Theravance Positive, Denali Encouraging, Redhill Clarifies Data
Stocks in News: TBPH, DNLI Theravance's TD-9855 shows positive effect in low blood pressure disorder study Theravance Biopharma ( TBPH ) reported positive data of a four-week data from a Phase 2 clinical trial of TD-9855. The candidate is an once-daily norepinephrine and serotonin reup...
Source: SeekingAlpha
Date: August, 03 2018 00:56
Midday Gainers / Losers (08/01/2018)
Gainers:  TCS +39% . NSYS +35% . RXII +26% . SODA +22% . NMRD +21% . GDS +19% . DHXM +19% . MRCY +19% . QUAD +19% . RCKY +18% . More news on: The Container Store Group, Inc., Nortech Systems Incorporated, RXI Pharmaceuticals Corporation, Stocks on the m...
Source: SeekingAlpha
Date: August, 01 2018 12:45
Nemaura Medical up 21%
Thinly traded Nemaura Medical ( NMRD +20.8% ) is up on more than a 4x surge in volume, albeit on turnover of only 102K shares. The stock is trying to break out of long-term downtrend that began in late January. More news on: Nemaura Medical, Inc., Abbott Laboratories, DexCom, Inc., Healt...
Source: SeekingAlpha
Date: August, 01 2018 12:40
Nemaura Initiates US FDA Studies, and Reports Positive Interim Data from Home-Use Portion of Study
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today announced it has initiated the first of a number of planned studies in supp...
Source: GlobeNewswire
Date: July, 31 2018 04:00
Midday Gainers / Losers (07/18/2018)
Gainers:  CPAH +55% . STAF +39% . MTSL +31% . CHRS +19% . EBF +15% . NXTD +13% . NMRD +13% . BBOX +12% . GWW +12% . ARC +11% . More news on: CounterPath Corporation, Staffing 360 Solutions, Inc., MER Telemanagement Solutions Ltd., Stocks on the move, , ...
Source: SeekingAlpha
Date: July, 18 2018 12:51
Midday Gainers / Losers (07/17/2018)
Gainers:  PED +51% . AMRH +47% . CDMO +25% . CSBR +23% . CLRB +18% . NMRD +16% . GBR +16% . MESO +15% . AQXP +14% . NSU +13% . More news on: PEDEVCO Corp., Ameri Holdings, Inc., Avid Bioservices, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: July, 17 2018 12:40
Nemaura Medical preparing for UK launch of sugarBEAT GMS; shares up 11%
Thinly traded small cap Nemaura Medical ( NMRD +11.3% ) is up on more than a 4x surge in volume, albeit on turnover of only 64K shares, on the heels of its announcement that it has placed an initial order for 12.5K sugarBEAT rechargeable transmitters ahead of its UK commercial launch. ...
Source: SeekingAlpha
Date: July, 17 2018 10:32
Nemaura Places SugarBEAT® Manufacturer Order for UK Commercial Launch
Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use by persons with diabetes, today announced it has placed an initial order with its designated UK-based contract manufacturer for ...
Source: Business Wire
Date: July, 17 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-092.302.20162.302.1324,353
2018-05-183.0153.01963.03013.0155,222
2018-05-173.0153.01963.03013.0155,222

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-177,1549,51475.1945Short
2018-12-142,9528,49634.7458Cover
2018-12-138392,56532.7096Cover
2018-12-122,20010,21521.5370Cover
2018-12-118507,87910.7882Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NMRD.


About Nemaura Medical, Inc. (NASDAQ: NMRD)

Logo for Nemaura Medical, Inc. (NASDAQ: NMRD)

Nemaura Medical Inc. OTCQB:NMRD is a medical technology company developing sugarBEAT as a non invasive, affordable and flexible glucose monitoring system for adjunctive use by diabetics. SugarBEAT consists of a disposable skin patch connected to a rechargeable transmitter, with an app displaying glucose readings.

 

 

 

Current Management

  • Dewan F H Chowdhury / CEO
  • Iain Anderson / CFO
  • Karrar Khan / Director, Prod. Dev.
  • David Scott / Director, Comm.
  • Richard Toon / Business Development
  • Salim Natha / NonExecutive Director, Independent Director, Compensation Committee Member
  • Timothy Johnson / Director
  • Thomas Moore / Director
  • Bashir Timol /

Current Share Structure

  • Market Cap: $339,733,520 - 03/16/2018
  • Authorized: 420,000,000 - 02/08/2018
  • Issue and Outstanding: 67,676,000 - 02/08/2018
  • Float: 34,941,010 - 11/17/2017

 


Recent Filings from (NASDAQ: NMRD)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: April, 26 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 10 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 10 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: March, 02 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: March, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 09 2018

 

 


Daily Technical Chart for (NASDAQ: NMRD)

Daily Technical Chart for (NASDAQ: NMRD)


Stay tuned for daily updates and more on (NASDAQ: NMRD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NMRD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NMRD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NMRD and does not buy, sell, or trade any shares of NMRD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/